Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Preclinical and clinical profile of Searle's fibrinogen antagonist

Nov. 10, 1997

TP-9201 covered by new U.S. patent

Nov. 10, 1997

Fibrinogen antagonists from Merck & Co.

Nov. 10, 1997

Spotlight on thrombin inhibitors

Nov. 10, 1997

ReoPro cleared in U.S. for expanded labeling

Nov. 7, 1997

Saruplase efficacy demonstrated in large patient study

Nov. 7, 1997

PEG-hirudin compared to established antithrombotic agents

Nov. 7, 1997

Akzo Nobel prepares two series of thrombin inhibitors

Nov. 7, 1997

Lefradafiban: oral prodrug for profound and sustained inhibition of platelet aggregation

Nov. 5, 1997

Teijin licenses new thrombolytic from Schering AG

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...